Efficacy, safety and implementation outcomes of Cabotegravir plus Rilpivirine long-acting by country in the Cabotegravir and rilpivirine implementation study in European locations (CARISEL)

C. Jonsson-Oldenbuettel, J. Ghosn,J. Olalla Sierra,M. van der Valk, T. Lutz, L. Belkhir, B. J. van Welzen, K. Hove, M. Ait-Khaled, R. DeMoor, G. Bontempo, C. L. Latham, B. Ngenzi, C. Okoli, C. A. Gutner, S. Iyer, M. Gill, M. Czarnogorski, R. D'Amico,J. van Wyk

HIV MEDICINE（2023）

引用 0|浏览0